165 related articles for article (PubMed ID: 16962758)
1. Dyspnoea at 6-min walk test in idiopathic pulmonary fibrosis: comparison with COPD.
Nishiyama O; Taniguchi H; Kondoh Y; Kimura T; Kato K; Ogawa T; Watanabe F; Arizono S
Respir Med; 2007 Apr; 101(4):833-8. PubMed ID: 16962758
[TBL] [Abstract][Full Text] [Related]
2. Health-related quality of life in patients with idiopathic pulmonary fibrosis. What is the main contributing factor?
Nishiyama O; Taniguchi H; Kondoh Y; Kimura T; Ogawa T; Watanabe F; Nishimura K
Respir Med; 2005 Apr; 99(4):408-14. PubMed ID: 15763446
[TBL] [Abstract][Full Text] [Related]
3. Six-minute walking test in cystic fibrosis adults with mild to moderate lung disease: comparison to healthy subjects.
Chetta A; Pisi G; Zanini A; Foresi A; Grzincich GL; Aiello M; Battistini A; Olivieri D
Respir Med; 2001 Dec; 95(12):986-91. PubMed ID: 11778797
[TBL] [Abstract][Full Text] [Related]
4. The body weight-walking distance product as related to lung function, anaerobic threshold and peak VO2 in COPD patients.
Chuang ML; Lin IF; Wasserman K
Respir Med; 2001 Jul; 95(7):618-26. PubMed ID: 11453321
[TBL] [Abstract][Full Text] [Related]
5. Airway obstruction and chronic exertional dyspnoea in patients with persistent bronchial asthma.
Filippelli M; Pacini F; Romagnoli I; Rosi E; Ottanelli R; Duranti R; Scano G
Respir Med; 2000 Jul; 94(7):694-701. PubMed ID: 10926342
[TBL] [Abstract][Full Text] [Related]
6. Quantitative 15 steps exercise oximetry as a marker of disease severity in patients with chronic obstructive pulmonary disease.
Kramer MR; Krivoruk V; Lebzelter J; Liani M; Fink G
Isr Med Assoc J; 1999 Nov; 1(3):165-8. PubMed ID: 10731326
[TBL] [Abstract][Full Text] [Related]
7. Physiological and symptom determinants of exercise performance in patients with chronic airway obstruction.
Foglio K; Carone M; Pagani M; Bianchi L; Jones PW; Ambrosino N
Respir Med; 2000 Mar; 94(3):256-63. PubMed ID: 10783937
[TBL] [Abstract][Full Text] [Related]
8. Dyspnoea with activities of daily living versus peak dyspnoea during exercise in male patients with COPD.
Oga T; Nishimura K; Tsukino M; Hajiro T; Mishima M
Respir Med; 2006 Jun; 100(6):965-71. PubMed ID: 16298519
[TBL] [Abstract][Full Text] [Related]
9. The distance-saturation product predicts mortality in idiopathic pulmonary fibrosis.
Lettieri CJ; Nathan SD; Browning RF; Barnett SD; Ahmad S; Shorr AF
Respir Med; 2006 Oct; 100(10):1734-41. PubMed ID: 16545950
[TBL] [Abstract][Full Text] [Related]
10. A potential role for sildenafil in the management of pulmonary hypertension in patients with parenchymal lung disease.
Madden BP; Allenby M; Loke TK; Sheth A
Vascul Pharmacol; 2006 May; 44(5):372-6. PubMed ID: 16574495
[TBL] [Abstract][Full Text] [Related]
11. Correlation of lung function tests with dyspnoea scale, 12 minute walking test and visual analogue scale in patients with COPD.
Guleria R; Behera D; Jindal SK
Indian J Chest Dis Allied Sci; 1989; 31(4):241-5. PubMed ID: 2638664
[TBL] [Abstract][Full Text] [Related]
12. Perception of bronchoconstriction in smokers with airflow limitation.
Ottanelli R; Rosi E; Ronchi MC; Grazzini M; Lanini B; Stendardi L; Romagnoli I; Bertini S; Duranti R; Scano G
Clin Sci (Lond); 2001 Nov; 101(5):515-22. PubMed ID: 11672457
[TBL] [Abstract][Full Text] [Related]
13. [Dyspnea and inspiratory effort capacity in COPD].
Noseda A; Carpiaux JP; Schmerber J; Yernault JC
Rev Mal Respir; 1993; 10(6):537-43. PubMed ID: 8122020
[TBL] [Abstract][Full Text] [Related]
14. [Dyspnea, respiratory mechanics and gas exchange in patients with idiopathic pulmonary fibrosis].
Wesołowski S; Meleniewska-Maciszewska A; Korzeniewska-Koseła M; Kuś J; Radwan L
Pneumonol Alergol Pol; 1997; 65(3-4):220-4. PubMed ID: 9489418
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of dynamic hyperinflation parameters and exercise capacity at maximal exercise in patients with COPD].
Ulubay G; Görek A; Savaş S; Oner Eyüboğlu F
Tuberk Toraks; 2005; 53(4):340-6. PubMed ID: 16456732
[TBL] [Abstract][Full Text] [Related]
16. Effect of oxygen on recovery from maximal exercise in patients with chronic obstructive pulmonary disease.
Stevenson NJ; Calverley PM
Thorax; 2004 Aug; 59(8):668-72. PubMed ID: 15282386
[TBL] [Abstract][Full Text] [Related]
17. Functional capacity in severe chronic obstructive pulmonary disease.
Inal-Ince D; Savci S; Coplu L; Arikan H
Saudi Med J; 2005 Jan; 26(1):84-9. PubMed ID: 15756359
[TBL] [Abstract][Full Text] [Related]
18. Tissue depletion and health related quality of life in patients with chronic obstructive pulmonary disease.
Mostert R; Goris A; Weling-Scheepers C; Wouters EF; Schols AM
Respir Med; 2000 Sep; 94(9):859-67. PubMed ID: 11001077
[TBL] [Abstract][Full Text] [Related]
19. The timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosis.
Hallstrand TS; Boitano LJ; Johnson WC; Spada CA; Hayes JG; Raghu G
Eur Respir J; 2005 Jan; 25(1):96-103. PubMed ID: 15640329
[TBL] [Abstract][Full Text] [Related]
20. Continuous and intermittent exercise responses in individuals with chronic obstructive pulmonary disease.
Sabapathy S; Kingsley RA; Schneider DA; Adams L; Morris NR
Thorax; 2004 Dec; 59(12):1026-31. PubMed ID: 15563700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
